Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

Cut-off Analysis of HLA-A and HLA-B/C Expression as a Potential Prognosticator of Favorable Survival in Patients With Metastatic Breast Cancer

STEFAN STEFANOVIC, RALPH WIRTZ, MARC SÜTTERLIN, UROS KARIC, ANDREAS SCHNEEWEISS, THOMAS M. DEUTSCH and MARKUS WALLWIENER
Anticancer Research April 2023, 43 (4) 1449-1454; DOI: https://doi.org/10.21873/anticanres.16293
STEFAN STEFANOVIC
1Department of Gynecology and Obstetrics, Mannheim University Hospital, University of Heidelberg, Mannheim, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: stefan.stefanovic@umm.de
RALPH WIRTZ
2Stratifyer Molecular Pathology GmbH, Cologne, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MARC SÜTTERLIN
1Department of Gynecology and Obstetrics, Mannheim University Hospital, University of Heidelberg, Mannheim, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
UROS KARIC
3Medical Statistics, IMDI Science Center, Belgrade, Serbia;
4Hospital for Infectious and Tropical Diseases, Belgrade University School of Medicine, Belgrade, Serbia;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ANDREAS SCHNEEWEISS
5National Center for Tumor Diseases, Heidelberg University Hospital, University of Heidelberg, Heidelberg, Germany;
6German Cancer Research Center (DKFZ), Heidelberg, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
THOMAS M. DEUTSCH
7Department of Gynecology and Obstetrics, Heidelberg University Hospital, University of Heidelberg, Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MARKUS WALLWIENER
7Department of Gynecology and Obstetrics, Heidelberg University Hospital, University of Heidelberg, Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 43 no. 4 1449-1454
DOI 
https://doi.org/10.21873/anticanres.16293
PubMed 
36974778

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received January 18, 2023
  • Revision received February 1, 2023
  • Accepted February 2, 2023
  • Published online March 27, 2023.

Copyright & Usage 
Copyright © 2023 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Author Information

  1. STEFAN STEFANOVIC1⇑,
  2. RALPH WIRTZ2,
  3. MARC SÜTTERLIN1,
  4. UROS KARIC3,4,
  5. ANDREAS SCHNEEWEISS5,6,
  6. THOMAS M. DEUTSCH7 and
  7. MARKUS WALLWIENER7
  1. 1Department of Gynecology and Obstetrics, Mannheim University Hospital, University of Heidelberg, Mannheim, Germany;
  2. 2Stratifyer Molecular Pathology GmbH, Cologne, Germany;
  3. 3Medical Statistics, IMDI Science Center, Belgrade, Serbia;
  4. 4Hospital for Infectious and Tropical Diseases, Belgrade University School of Medicine, Belgrade, Serbia;
  5. 5National Center for Tumor Diseases, Heidelberg University Hospital, University of Heidelberg, Heidelberg, Germany;
  6. 6German Cancer Research Center (DKFZ), Heidelberg, Germany;
  7. 7Department of Gynecology and Obstetrics, Heidelberg University Hospital, University of Heidelberg, Heidelberg, Germany
  1. Correspondence to: PD Dr. med. Stefan Stefanovic, MHBA, University Medical Center Mannheim, University of Heidelberg, Department of Gynecology and Obstetrics, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany. Tel: +49 6213838552, Fax: +49 6213833814, e-mail: stefan.stefanovic{at}umm.de
View Full Text
PreviousNext
Back to top

In this issue

Anticancer Research: 43 (4)
Anticancer Research
Vol. 43, Issue 4
April 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Cut-off Analysis of HLA-A and HLA-B/C Expression as a Potential Prognosticator of Favorable Survival in Patients With Metastatic Breast Cancer
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
4 + 1 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Cut-off Analysis of HLA-A and HLA-B/C Expression as a Potential Prognosticator of Favorable Survival in Patients With Metastatic Breast Cancer
STEFAN STEFANOVIC, RALPH WIRTZ, MARC SÜTTERLIN, UROS KARIC, ANDREAS SCHNEEWEISS, THOMAS M. DEUTSCH, MARKUS WALLWIENER
Anticancer Research Apr 2023, 43 (4) 1449-1454; DOI: 10.21873/anticanres.16293

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Cut-off Analysis of HLA-A and HLA-B/C Expression as a Potential Prognosticator of Favorable Survival in Patients With Metastatic Breast Cancer
STEFAN STEFANOVIC, RALPH WIRTZ, MARC SÜTTERLIN, UROS KARIC, ANDREAS SCHNEEWEISS, THOMAS M. DEUTSCH, MARKUS WALLWIENER
Anticancer Research Apr 2023, 43 (4) 1449-1454; DOI: 10.21873/anticanres.16293
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Conclusion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Anti-tumor Effect of Activated Canine B Cells With Interleukin-21 and Anti-B Cell Receptor
  • Claudin-10 in the Blood Brain Barrier Function of Cerebral Endothelial Cells and Transendothelial Invasion of Breast Cancer Cells
  • Development of Genetically Engineered Feeder Cells for Natural Killer Cell Expansion
Show more Experimental Studies

Similar Articles

Keywords

  • breast cancer
  • HLA-A
  • HLA-B/C
  • cut-off
  • prognosticator
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire